Universal Medica Group and EVERSANA Partner
Universal Medica Group-consulting form for healthcare and pharma-and EVERSANA-provider of commercial services in life sciences-announced that they have entered into a partnership for the life sciences and healthcare industry.
The companies plan to provide medical information and programs-with infrastructure, technology, workflows, and clinical staffing-and pharmacovigilance services throughout Europe, Asia, and North, Central, and South America.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.
